Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Other Accumulated Expenses: 2016-2024

Historic Other Accumulated Expenses for Mesoblast (MESO) over the last 9 years, with Jun 2024 value amounting to $385,000.

  • Mesoblast's Other Accumulated Expenses rose 4.90% to $385,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $385,000, marking a year-over-year increase of 4.90%. This contributed to the annual value of $385,000 for FY2024, which is 4.90% up from last year.
  • Latest data reveals that Mesoblast reported Other Accumulated Expenses of $385,000 as of FY2024, which was up 4.90% from $367,000 recorded in FY2023.
  • Over the past 5 years, Mesoblast's Other Accumulated Expenses peaked at $1.8 million during FY2021, and registered a low of $367,000 during FY2023.
  • For the 3-year period, Mesoblast's Other Accumulated Expenses averaged around $668,667, with its median value being $385,000 (2024).
  • Per our database at Business Quant, Mesoblast's Other Accumulated Expenses soared by 75.12% in 2021 and then tumbled by 70.73% in 2023.
  • Mesoblast's Other Accumulated Expenses (Yearly) stood at $1.0 million in 2020, then skyrocketed by 75.12% to $1.8 million in 2021, then decreased by 28.75% to $1.3 million in 2022, then slumped by 70.73% to $367,000 in 2023, then increased by 4.90% to $385,000 in 2024.